Ross Drugs Durable Medical Equipment & Medical Supplies Location: 125 Foxglove Dr, Mount Sterling, Kentucky 40353 Phone: (859) 498-1004 |
Cvs Pharmacy #06337 Durable Medical Equipment & Medical Supplies Location: 1201 Indian Mound Dr, Mount Sterling, Kentucky 40353 Phone: (859) 498-4320 |
Ross Surgical DME Supplier - Oxygen Equipment & Supplies Location: 125 Foxglove Dr, Mount Sterling, Kentucky 40353 Phone: (859) 498-9711 |
Whitaker Pharmacy Durable Medical Equipment & Medical Supplies Location: 570 Indian Mound Dr, Mount Sterling, Kentucky 40353 Phone: (859) 498-3141 |
Kroger Pharmacy L-712 Durable Medical Equipment & Medical Supplies Location: 810 Indian Mound Dr, Mount Sterling, Kentucky 40353 Phone: (859) 497-9696 |
Walmart Pharmacy 10-1140 Durable Medical Equipment & Medical Supplies Location: 499 Indian Mound Dr, Mount Sterling, Kentucky 40353 Phone: (859) 498-1392 |
Carrington Drug Durable Medical Equipment & Medical Supplies Location: 506 Maysville Rd, Mount Sterling, Kentucky 40353 Phone: (859) 498-3464 |
Wecare Medical Llc DME Supplier - Oxygen Equipment & Supplies Location: 115e Locust St, Mount Sterling, Kentucky 40353 Phone: (859) 499-4220 |
Kenney Orthopedics Of Mt Sterling Durable Medical Equipment & Medical Supplies Location: 250 Foxglove Dr, Mount Sterling, Kentucky 40353 Phone: (859) 498-1888 |
Bluegrass Vision Group Pllc Medicare Supplier Location: 25 Sterling Way, Mount Sterling, Kentucky 40353 Phone: (859) 498-4800 |
News Archive
St. Luke's Cancer Center is a leader in offering clinical trials for patients with melanoma, the most unusual type of skin cancer and also the most deadly. Physicians such as Sanjiv Agarwala, MD, Chief of Medical Oncology and Hematology for St. Luke's University Health Network and an internationally recognized melanoma specialist, are committed to bringing the most promising studies to the Lehigh Valley.
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that Merck KGaA ("Merck") has completed its acquisition of Millipore (the "Acquisition") as of July 14, 2010. As part of the transaction, all issued and outstanding shares of Millipore common stock were exchanged for $107 per share in cash.
"I was completely stunned. Nearly everything he was saying to me was going right over the top of my head. I could see his lips moving but I could not process or absorb his words"- a patient on hearing her doctor diagnose breast cancer.
Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).
› Verified 1 days ago